641 followers
RT @FrontImmunol: New Research: Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Prog…
RT @FrontImmunol: New Research: Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Prog…
RT @FrontImmunol: New Research: Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Prog…
New Research: Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands: Dendritic cell (DC) vaccines have proven to be a valuable tool in cancer immune therapy. With… https://t.co/rFv2X